18611-32-0

Upstream product

• 18606-50-3 1-(3-tert-butyl-4-hydroxy-5-methyl-phenyl)-ethanone 
• 7789-45-9 copper(II)bromide 

Downstream Products

• 118788-44-6 3-(3-tert-butyl-5-methyl-4-hydroxyphenyl)-7H-thiazolo[3,2-b][1,2,4]triazin-7-one 

Relevant academic research and scientific papers

Substituted 3-phenyl-7H-thiazol[3,2-b][1,2,4]-triazin-7-ones

Novel substituted 3-phenyl-7H-thiazolo[3,2-b][1,2,4]-triazin-7-ones of the formula I are disclosed STR1 in which R1, R2 and R3 have the meaning recited in the specification. The compounds are suitable for prevention and treatment of inflammatory disorders.

5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6H-1,3,4-thiadiazines

Novel 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6H-1,3,4-thiadiazines of the general formula I STR1 in which R1 =C1 -C4 -alkyl, R2 =H or C1 -C3 -alkyl R3 and R4 =independently of one another, optionally substituted and optionally O- or S-interrupted alkyl, alkenyl or alkynyl groups, it being possible for one of the two radicals to also be H, or R3 +R4 together with the nitrogen atom to which they are bound, may denote an optionally substituted 4- to 7-membered ring which optionally contains a further heteroatom (O, S or N), and the physiologically acceptable acid-addition salts thereof. The compounds are primarily suitable for prevention and treatment of inflammatory--in particular inflammatory rheumatic--disorders and/or pain.